News

Filter

Current filters:

Mallinckrodt

1 to 9 of 24 results

Mallinckrodt 4th-qtr sales and earnings beat analysts’ expectations

20-11-2014

US drugmaker Mallinckrodt has reported a strong set of financial results for the fourth-quarter and full…

FinancialMallinckrodtPharmaceutical

Mallinckrodt questions FDA reasoning on methylphenidate ER reclassification

13-11-2014

US drugmaker Mallinckrodt says it has been informed by the Food and Drug Administration that the agency…

ConcertaGenericsJohnson & JohnsonMallinckrodtMethylphenidate Extended-Release TabletsNeurologicalRegulationUSA

Horizon Pharma buys US rights to Nuvo’s Pennsaid for $45 million

19-10-2014

Canadian specialty drugmaker Nuvo Research says it has completed the sale of its osteoarthritis pain…

Anti-Arthritics/RheumaticsHorizon PharmaLicensingMallinckrodtNuvo ResearchPennsaidPharmaceuticalUSA

Mallinckrodt’s MNK-155 shows efficacy in Ph III acute pain trial

Mallinckrodt’s MNK-155 shows efficacy in Ph III acute pain trial

05-09-2014

US drugmaker Mallinckrodt reported that a Phase III efficacy trial of investigational MNK-155 met the…

AcuformDepomedMallinckrodtMNK-155NeurologicalPharmaceuticalResearch

Mylan debuts generic Zyprexa Zydis in USA; Actavis Exalgo copy approved

Mylan debuts generic Zyprexa Zydis in USA; Actavis Exalgo copy approved

14-05-2014

US generic drugmaker Mylan says it has launched Olanzapine Orally Disintegrating tablets (ODT), 5mg,…

ActavisEli LillyExalgoGenericsMallinckrodtMarkets & MarketingMylanNeurologicalRegulationUSAZyprexa

Mallinckrodt to acquire Questcor Pharma for around $5.6 billion

Mallinckrodt to acquire Questcor Pharma for around $5.6 billion

07-04-2014

In a second M&A deal so far this year, Ireland-headquartered Mallinckrodt says it has entered a definitive…

ActharBusinessBusiness FinanceCorporate financeMallinckrodtMergers & AcquisitionsPharmaceuticalPharmaceuticalsQuestcor PharmaStock market

Mallinckrodt gains FDA approval for Xartemis XR

Mallinckrodt gains FDA approval for Xartemis XR

12-03-2014

The US Food and Drug Administration has approved Ireland-headquartered specially drugmaker Mallinckrodt’s…

DepomedMallinckrodtNeurologicalNorth AmericaPharmaceuticalRegulationUSAXartemis XR

Mallinckrodt to buy Cadence Pharma for around $1.3 billion

12-02-2014

Ireland-headquartered specialty drugmaker Mallinckrodt, spun off by Covidien last year, has entered into…

Cadence PharmaceuticalsMallinckrodtMergers & AcquisitionsOfirmevPharmaceutical

1 to 9 of 24 results

COMPANY SPOTLIGHT

Menarini

Back to top